Disease-modifying therapies alter gut microbial composition in MS

OBJECTIVE: To determine the effects of the disease-modifying therapies, glatiramer acetate (GA) and dimethyl fumarate (DMF), on the gut microbiota in patients with MS. METHODS: Participants with relapsing MS who were either treatment-naive or treated with GA or DMF were recruited. Peripheral blood m...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz Sand, Ilana, Zhu, Yunjiao, Ntranos, Achilles, Clemente, Jose C., Cekanaviciute, Egle, Brandstadter, Rachel, Crabtree-Hartman, Elizabeth, Singh, Sneha, Bencosme, Yadira, Debelius, Justine, Knight, Rob, Cree, Bruce A.C., Baranzini, Sergio E., Casaccia, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278850/
https://www.ncbi.nlm.nih.gov/pubmed/30568995
http://dx.doi.org/10.1212/NXI.0000000000000517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278850/
https://www.ncbi.nlm.nih.gov/pubmed/30568995
http://dx.doi.org/10.1212/NXI.0000000000000517

Ejemplares similares